Quick Takeaways
- Orin Hirschman filed SCHEDULE 13G for FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC).
- Disclosed ownership: 5.7%.
- Date of event: 31 Mar 2026.
Orin Hirschman - 31 Mar 2026 SCHEDULE 13G Report for FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC)
- Filing Manager
- Orin Hirschman
- Reporting Manager
- Orin Hirschman
- Symbol
- FENC
- Shares outstanding
- 34,763,175 shares
- Disclosed Ownership
- 1,981,501 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G
- Filing time
- 28 Apr 2026, 16:15:30 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Orin Hirschman disclosed 5.7% ownership in FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Apr 2026, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orin Hirschman | 5.7% | 1,981,501 | 1,981,501 | 0 | /s/ Orin Hirschman | Orin Hirschman | |
| AIGH Capital Management LLC | 5.7% | 1,981,501 | 1,981,501 | 0 | /s/ Orin Hirschman | Orin Hirschman, Managing Member |